Med-X (2025)
About this raise
Med-X is raising funds on Dealmaker Securities. The company is revolutionizing the pesticide industry with its clean and green pesticide alternative. Med-X’s Nature-Cide is natural and plant-based and helps in fighting pests without the harmful effects of chemicals. The company has several strategic partnerships and a loyal customer base and has reported a 200% revenue growth to $1.89 million in 2023. Matthew Mills founded Med-X in February 2014. The current crowdfunding campaign has a minimum target of $10,002 and a maximum target of $1.23 million. The campaign proceeds will be used for acquisitions, marketing, working capital, hiring, product registration, and research and development.
Investment Overview
Invested : $1,672,671
Deal Terms
Total Commitments
- Platform
- DealMaker Securities
- Start Date
- 05/29/2024
- Close Date
- 04/27/2025
$10,002
$5,000,000
$600
Equity - Common
Growth Stage
RegCF
$3.00
$50,894,025
Company & Team
Company
- Year Founded
- 2014
- Industry
- Consumer Products, Goods & Services
- Tech Sector
- Distribution Model
- B2B/B2C
- Margin
- Medium
- Capital Intensity
- High
Financials
- Revenue +2% YoY
-
$1,894,784
as of FY2023
- Monthly Burn
-
Profitable
as of FY2023
-
Cash on Hand
-
$65,747
as of FY2023
- Gross Margin
-
13%
as of FY2023
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Ratings 
Company Funding & Growth
Funding history
- Total Prior Capital Raised
- $14,326,801
- VC Backed?
- No
| Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|
| 04/27/2025 | DealMaker Securities | $50,894,025 | $1,672,671 | Equity - Common | Funded | RegCF |
| 11/09/2023 | Dalmore Group | $102,217,405 | $3,936,422 | Equity - Common | Funded | RegA+ |
| 05/23/2023 | PicMii | $43,211,544 | $0 | Equity - Common | Not Funded | RegCF |
| 09/10/2021 | truCrowd | $88,552,772 | $15,595 | Equity - Common | Funded | RegCF |
| 06/29/2019 | StartEngine | - | $7,000,471 | Equity - Common | Funded | RegA+ |
Growth Charts
Revenue History
Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.
Valuation History
Price per Share History
Note: Share prices shown in earlier rounds may not be indicative of any stock splits.